The polymer additive manufacturing market is expected to grow significantly from 2024 to 2031, driven by cost efficiency, customization, and sustainability benefits. Key growth opportunities include advancements in bioprinting, supply chain resilience, and industry partnerships. North America leads the market due to strong industrial adoption.

The global injection molding market is projected to reach $418.39 billion by 2031, driven by growing demand from the automotive and packaging industries. Metal injection molding is expected to see the highest growth rate during the forecast period.

The global aerospace 3D printing market is poised for significant growth, with a projected CAGR of 18.79% from 2025 to 2033, driven by increasing demand for lightweight and fuel-efficient aircraft, and efforts to minimize carbon emissions and bolster national defense industries.

Proto Labs beat earnings forecasts in Q3, with sales of $125.6 million and earnings of $0.47 per share, despite a decline in revenue and earnings compared to the prior year. The company's CEO cited 'continued dynamic challenges in the manufacturing sector' as the reason for the revenue decline. Proto Labs provided Q4 guidance, forecasting sales between $115-$123 million and GAAP earnings between $0.10-$0.18 per share.

The global additive manufacturing market is projected to reach $91.59 billion by 2031, growing at a CAGR of 20.8% due to rising demand for cost-efficient production, customized products, and technological advancements in 3D printing. Industrial 3D printers dominate the market, and the laser beam melting (LBM) technology is expected to lead the growth.

Proto Labs launched Axtra3D Hybrid PhotoSynthesis (HPS) technology, which expands its 3D printing capabilities. HPS employs a precision laser and a digital light processing system to capture images of internal and external part structures, overcoming previous 3D printing limitations.

The vacuum casting machine market is expected to grow at a CAGR of 6.1% and reach a value of USD 5.3 billion by 2034, driven by increasing demand from industries like automotive and medical for intricate and complex components.

Cantor Fitzgerald analyst Troy Jensen initiated coverage on Proto Labs, Inc. (NYSE:PRLB) with an Overweight rating and price target of $44.00. The analyst writes that the company is well-placed to capitalize on a growing market and capture increased growth in production applications. With its hybrid business model offering in-house manufacturing and a network of suppliers, Proto Labs stands out in the digital manufacturing market, says the analyst. Proto Labs is primed to benefit from the ongoing shift towards digital manufacturing, and its entirely digital end-to-end manufacturing service resonates with customers, offering a wide range ...Full story available on Benzinga.com

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst Subbu Nambi initiated coverage on Twist Bioscience Corporation (NASDAQ:TWST) with a Buy rating, while announcing a price target of $53. Twist Bioscience shares gained 6.8% to close at $46.98 on Tuesday. See how other analysts view this stock. BMO Capital analyst Fadi Chamoun initiated coverage on Old Dominion Freight Line, Inc. (NASDAQ:ODFL) with an Outperform rating and announced a price target of $210. Old ...Full story available on Benzinga.com

PRLB earnings call for the period ending March 31, 2024.

Proto Labs (PRLB) delivered earnings and revenue surprises of 33.33% and 3.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Proto Labs' (PRLB) first-quarter 2024 results are likely to reflect the impacts of lower order levels seen in the earlier part of the quarter.